Market Access/ News/ News Takeda’s bleeding disorder drug Veyvondi backed for NHS use Phil Taylor Haematology, NHS England, Takeda, Veyvondi, von Willebrand disease 0 Comment NHS England has recommended that patients with von Willebrand disease (VWD) be treated with Takeda’s Veyvondi, making it Share X Takeda’s bleeding disorder drug Veyvondi backed for NHS use https://pharmaphorum.com/news/takedas-bleeding-disorder-drug-veyvondi-backed-for-nhs-use/
News Shire’s von Willebrand disease therapy Veyvondi approved in EU Richard Staines Shire, von Willebrand disease 0 Comment The European Commission has approved Shire’s Veyvondi for treatment of the bleeding disorder von Willebrand disease (VWD). VWD Share X Shire’s von Willebrand disease therapy Veyvondi approved in EU https://pharmaphorum.com/news/shires-von-willebrand-disease-therapy-veyvondi-approved-in-eu/